1-(6-Chloro-1H-indol-3-yl)-2,2,2-trifluoroethan-1-one, 98%, 1g

2,2'-Sulfonyldiethanol (65% in water), 95.0%, 5g

2-(tert-Butoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

Oxygen bottles acc. to Winkler, 250 to 300 ml, 19/26, 1 Piece

2-Chloro-n-{4-[(2,6-dimethylmorpholin-4-yl)sulfonyl]phenyl}acetamide, 97%, 100mg

5-(THIOPHEN-2-YLMETHYL)-6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE, 95.0%, 250mg

N,N'-Bis(2-hydroxyethyl)oxamide>98.0%(N)5g

2,6-Difluoro-4-methoxyphenol, 97%, 10g

3-BENZYL-1H-INDAZOLE, 95%, 1g

tert-Butyl 2-chloro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 100mg

(3-(Butylcarbamoyl)phenyl)boronic acid, 95.0%, 50mg

1-(Piperidin-1-yl)hexadecan-1-one, 98%, 5g

(R)-2-((tert-butoxycarbonyl)amino)-3-(6-chloro-1H-indol-3-yl)propanoic acid, 98%, 250mg